The National Human Genome Research Institute announced a number of key personnel changes, including the appointment of a new scientific director to run its intramural research program, a new director for the extramural program that oversaw the Human Genome Project and new advisors in the Office of the Director.

"This is a very exciting time for the National Human Genome Research Institute," said Director Francis S. Collins, "As we move to finish the human genome sequence in April 2003, the institute has been conducting a yearlong planning effort to prepare for the next phase of genomic research. It's only natural that the institute itself would also evolve. The new team promises to be a powerhouse for genomic research."

New appointments include: Eric D. Green, Scientific Director and director of NHGRI's Division of Intramural Research; William A. Gahl, intramural Clinical Director; and Mark S. Guyer, Director of the Division of Extramural Research, along with two DER Associate Directors, Jane L. Peterson, and Bettie J. Graham.

In addition, NHGRI's Office of the Director is adding new staff, including naming Christopher Austin, to the newly created position of Senior Advisor to the Director for Translational Research, and Jean Jenkins, as Senior Clinical Advisor.

As Senior Advisor to the Director for Translational Research, Dr. Austin will explore dissemination to academic investigators of the high-throughput technologies used in the private sector for deriving small molecule probes of biological pathways. He will also expand relationships with pharmaceutical and biotech companies, and focus on translating the genomic data produced through the Human Genome Project into new therapeutic strategies.

Dr. Jenkins will continue NHGRI's mission of educating health professionals and the public about the role of genetic medicine in the clinic, as well as the health and societal implications of the Human Genome Project. In addition to her part-time position at NHGRI, Dr. Jenkins will continue to serve as the Nurse Clinical Specialist Consultant in Cancer Genetics at the National Cancer Institute (NCI), where she has been since 1997.